Matritech (NASDAQ - NMPS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William J. Leiby who wrote (518)	12/23/1997 8:23:00 AM
From: John McCarthy	Read Replies (1) of 849

William - I asked Richard Harmon for his views on the Colon Cancer thingie. His response is below. Sorry for the Coal - but have a good Holiday anyway. Regards, John John: I haven't seen anything published on NMPs and colon since a PNAS paper in '94, and that was from Matritech itself. Might be false logic, but, if the diagnostic was any good, don't you think we'd see some manuscripts? Plus, they keep comparing it in press releases to CEA, which, while they refer to it as a gold standard, is not very useful. This "spin" makes me worry. I also found it strange that they were filing a 510-K. Seems to me that their posture is that the colon test is at least as good as something that is ackowledged as not so hot. I'd get ahold of the test protocol and determine its complexity relative to CEA testing. If it's simple and straightforward, I'd say that it might be used to monitor disease progression in a subset of patients where diagnosis has already been made. Please consider that I haven't looked seriously at the company or its projects in a couple of years. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next